English

Ossur Hf : Board decisions following the Annual General Meeting 14 March 2014

Report this content 
Announcement from Össur hf. No. 09/2014
Reykjavik, 14 March 2014

       Board decisions following the Annual General Meeting 14 March 2014


Allocation of responsibilities

Mr.  Niels Jacobsen was re-elected as Chairman of the Board of Directors and Dr.
Kristján Tómas Ragnarsson was re-elected as Vice Chairman.

Mr.  Arne Boye Nielsen, Mrs. Guðbjörg Edda Eggertsdóttir and Dr. Svafa Grönfeldt
were appointed to the Company's Audit Committee.

Authorization for management to purchase own shares on behalf of the Company

With  reference  to  the  authorization  to  purchase own shares approved by the
Company's  Annual General  Meeting held  today, the  Board granted management an
authorization  to purchase own  shares on behalf  of the Company  in one or more
transactions.

Terms and conditions:
  * A purchase shall be made with the aim to maintain a desired capital level of
    net interest bearing debt in accordance with the Company's Dividend Policy,
    as amended by the Board in February 2014.
  * The purchase price shall not be more than 10% above or 10% below the market
    price on NASDAQ OMX where the shares are purchased, but always within the
    limits of the law at the time of purchase (currently the closing price on
    NASDAQ OMX where the shares are purchased the day before the purchase).
  * A purchase shall always be carried out within the limits of the
    authorization of the Annual General Meeting and in accordance with
    applicable law and rules.
  * The authorization is valid until the next Annual General Meeting in 2015.

Össur press releases by e-mail


If  you wish to  receive Össur press  releases by e-mail  please register at the
following web-site: http://www.ossur.com/investormailings.

About Össur
Össur  (NASDAQ OMX: OSSR)  is a global  leader in non-invasive orthopaedics that
help  people  live  a  life  without  limitations.   Its  business is focused on
improving  people's  mobility  through  the  delivery of innovative technologies
within  the  fields  of  braces,  supports,  prosthetic  limbs  and  compression
therapy.   A  recognized  "Technology  Pioneer",  Össur invests significantly in
research   and   product  development;  its  award-winning  designs  ensuring  a
consistently  strong position in  the market.   Successful  patient and clinical
outcomes  are further  empowered via  Össur's educational  programs and business
solutions.   Headquartered  in  Iceland,  Össur  has  major  operations  in  the
Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com

Forward-Looking Statements
This press release includes "forward-looking statements" which involve risks and
uncertainties that could cause actual results to differ materially from results
expressed or implied by these statements. Össur hf. undertakes no obligation and
does not intend to update these forward-looking statements to reflect events or
circumstances occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this press release. All forward-looking statements are qualified in
their entirety by this cautionary statement.
 

Subscribe